Founded in 2000 and is headquartered in Tubingen, Germany
CureVac raised more than $213 million in its IPO. That is on top of the $640 million in financing the company raised in a private round that closed in July.
CVAC says its Phase 3 trial for a Covid-19 vaccine will publish results in Q4 2020 and the IPO enjoys strong investor support.
30% German Gov
Bill Gates
1) https://finviz.com/quote.ashx?t=cvac
What's your play for $CVAC??